LEDIKAST LEDIPASVIR TABLETS

Get a Price/Quote

LEDIKAST LEDIPASVIR TABLETS Specification

Pacakaging (Quantity Per Box)
28 Tablets

Origin of Medicine
Allopathic

Indication
Treatment of Hepatitis C Genotype 1 infection

Salt Composition
Ledipasvir 90mg

Dosage Form
Oral tablet

Drug Type
Prescription medicine

Ingredients
Ledipasvir

Physical Form
Tablets

Function
Antiviral medication for hepatitis C

Recommended For
Chronic Hepatitis C Infection

Dosage
As directed by the physician

Dosage Guidelines
Once daily or as prescribed

Suitable For
Adults

Quantity
28 Tablets per box

Storage Instructions
Store in a cool, dry place below 30C. Protect from light and moisture.

Brand Name
LEDIKAST

Packing Type
Blister strip in carton box

Side Effects
Fatigue, headache, nausea, diarrhea, insomnia

Shelf Life
24 months

Caution
Not for use in patients under 18 years

Color
Yellow

Prescription Required
Yes

Regulatory Approval
US FDA and DCGI approved

LEDIKAST LEDIPASVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About LEDIKAST LEDIPASVIR TABLETS

Ledikast Tablets

Specifications:-

Strength:90 mg +400 mg
Form:Tablet
Manufacturer:Aprazer
Brand:LEDIKAST
Packaging Size:pack of 28 tablets
Composition:Ledipasvir & Sofosbuvir

Note :-LEDIKAST Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug................

Mechanism of Action

LEDIKAST tablets contain Ledipasvir, which targets and inhibits specific enzymes required for hepatitis C virus replication. By disrupting the viral lifecycle, this medication assists in reducing and eventually clearing viral load in diagnosed adults.

Regulatory Approval

LEDIKAST is approved by both US FDA and DCGI, ensuring its efficacy and safety for managing chronic Hepatitis C infection. Physicians in various countries may prescribe it, and its compliance with major regulatory bodies supports its reliability.

Packaging and Storage

Each box of LEDIKAST contains 28 yellow tablets, packed in blister strips and protected in a carton box. To maintain potency, tablets should be stored below 30C in a cool, dry location, shielded from light and moisture.

FAQs of LEDIKAST LEDIPASVIR TABLETS:

Q: How should LEDIKAST tablets be taken for optimal effectiveness?

A: LEDIKAST tablets are recommended to be taken once daily or as directed by a physician. Consistency in dosing time is helpful, and they should be swallowed whole with water, without crushing or chewing.

Q: What are the potential side effects associated with LEDIKAST tablets?

A: Common side effects include fatigue, headache, nausea, diarrhea, and insomnia. If you experience severe discomfort or unexpected symptoms, consult with your healthcare provider.

Q: When is LEDIKAST prescribed, and for which patients?

A: LEDIKAST is prescribed for managing chronic Hepatitis C Genotype 1 infection in adults. It is not recommended for use in patients under 18 years of age.

Q: Where should LEDIKAST tablets be stored to maintain their efficacy?

A: Store LEDIKAST tablets below 30C in a cool, dry place, protected from light and moisture. Ensure that the tablets remain in their blister packaging until used.

Q: What is the process for obtaining LEDIKAST tablets?

A: LEDIKAST is a prescription medicine. It can be obtained from licensed pharmacies or authorized distributors after consultation with a physician who determines your suitability for the treatment.

Q: What are the benefits of using LEDIKAST for hepatitis C infection?

A: LEDIKAST helps suppress hepatitis C virus replication, potentially leading to the clearance of the virus and improved liver health for patients with Genotype 1 infection.

Tell us about your requirement